The trademark PregVit was filed by Georen Pharmaceuticals (Proprietary) Limited, a corporation established under the laws of the Republic of South Africa (the "Applicant"). The application was published for oppositions on October 18, 2010, and received one opposition filed on January 17, 2011 by Ambe Limited on Likelihood of confusion. the opponent was represented by WILDBORE & GIBBONS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 17, 2011
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
The application claimed as seniority of "BX" trademark 1152954 registered on May 12, 2008 and filed on February 11, 2008 which was accepted by the office.